iShares Nasdaq US Biotechnology UCITS ETF
$10.72+$0.04 (+0.37%)
iShares Nasdaq US Biotechnology UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 1.38% below the high.
LSE · PAVG.L · GBP
Stock price, dividends
Quote as of Nov 2, 2026, 08:02 AM UTC. Cached market data; not a live quote.
One-year closing-price history · GBP. Historical prices are not a forecast.
Global X U.S. Infrastructure Development UCITS ETF USD’s quoted price sits in the lower half of its reported 52-week range, 12.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Global X U.S. Infrastructure Development UCITS ETF USD’s forward annual dividend is £0.16 per share, paid semi-annual. The forward yield is 0.44% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The investment objective of the Fund is to provide investment results that closely correspond, before fees and expenses, generally to the price and yield performance of the Indxx U.S. Infrastructure Development v2 Index
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 2, 2026, 08:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$10.72+$0.04 (+0.37%)
iShares Nasdaq US Biotechnology UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 1.38% below the high.
£97.41+£0.04 (+0.04%)
JPMorgan ETFs (Ireland) ICAV - EUR IG Corporate Bond Active UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 1.55% below the high.
€8.24+€0.05 (+0.61%)
Global X Superdividend UCITS ETF USD’s quoted price sits in the lower half of its reported 52-week range, 10.05% below the high.
$41.18+$0.71 (+1.74%)
Franklin FTSE Asia ex China ex Japan UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 14.66% below the high.
£93.13-£0.18 (-0.19%)
State Street SPDR FTSE UK All Share UCITS ETF (Acc)’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
£6.89-£0.04 (-0.55%)
State Street SPDR FTSE UK All Share UCITS ETF (Dist)’s quoted price sits in the upper half of its reported 52-week range, 5.21% below the high.
£28.23-£0.47 (-1.65%)
HSBC MSCI World Climate Paris Aligned UCITS ETF’s quoted price sits in the upper half of its reported 52-week range, 3.7% below the high.
£12.21-£0.28 (-2.24%)
Global X - Nasdaq 100 Covered Call UCITS ETF’s quoted price sits in the lower half of its reported 52-week range, 7.01% below the high.